ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IONS Ionis Pharmaceuticals Inc

43.09
0.08 (0.19%)
After Hours
Last Updated: 07:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.08 0.19% 43.09 07:30:00
Open Price Low Price High Price Close Price Previous Close
43.15 42.62 43.62 43.09 43.01
more quote information »

Recent News

Date Time Source Heading
25/4/202421:00PRNUSIonis Publishes 2023 Corporate Responsibility Report
23/4/202421:05PRNUSIonis to hold first quarter 2024 financial results webcast
07/4/202423:48PRNUSIonis presents positive results from Phase 3 Balance study..
01/4/202422:05PRNUSIonis to present at upcoming investor conferences
28/3/202422:05PRNUSIonis to hold olezarsen Phase 3 data webcast
25/3/202423:18PRNUSPositive olezarsen Phase 3 data in familial chylomicronemia..
13/3/202422:00PRNUSIonis announces positive results from Phase 2 study of..
06/3/202423:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
05/3/202411:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202411:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202411:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202411:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202411:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202401:10EDGAR2Form 8-K - Current report
01/3/202401:05PRNUSIonis announces new chief global product strategy officer to..
28/2/202423:05PRNUSIonis to present at upcoming investor conferences
22/2/202403:17EDGAR2Form 8-K - Current report
21/2/202423:00PRNUSIonis reports fourth quarter and full year 2023 financial..
21/2/202402:39EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
17/2/202411:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202408:34EDGAR2Form 144 - Report of proposed sale of securities
15/2/202423:00PRNUSOlezarsen receives Orphan Drug designation from U.S. FDA for..
15/2/202402:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202422:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:00PRNUSEplontersen granted U.S. FDA Fast Track designation for..
07/2/202423:05PRNUSIonis to hold fourth quarter and full year 2023 financial..
03/2/202411:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202411:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202411:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202411:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202411:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202411:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202411:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202411:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202409:34EDGAR2Form 144 - Report of proposed sale of securities
03/2/202409:31EDGAR2Form 144 - Report of proposed sale of securities
03/2/202409:30EDGAR2Form 144 - Report of proposed sale of securities
03/2/202409:28EDGAR2Form 144 - Report of proposed sale of securities
03/2/202409:25EDGAR2Form 144 - Report of proposed sale of securities
03/2/202409:23EDGAR2Form 144 - Report of proposed sale of securities
03/2/202409:21EDGAR2Form 144 - Report of proposed sale of securities
03/2/202409:19EDGAR2Form 144 - Report of proposed sale of securities
01/2/202413:30EDGAR2Form 144 - Report of proposed sale of securities
30/1/202409:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202409:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202406:37EDGAR2Form 144 - Report of proposed sale of securities
27/1/202406:09EDGAR2Form 144 - Report of proposed sale of securities
22/1/202423:10EDGAR2Form 8-K - Current report
22/1/202423:00PRNUSIonis announces positive topline results from Phase 3..
19/1/202410:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock